Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giuseppe Ippolito and Chiara Agrati.
Giuseppe Ippolito
Connection Strength
4.891
Chiara Agrati
  1. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
    View in: PubMed
    Score: 0.886
  2. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection. Cells. 2021 08 17; 10(8).
    View in: PubMed
    Score: 0.241
  3. COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial. Front Immunol. 2021; 12:704110.
    View in: PubMed
    Score: 0.240
  4. Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine. Microorganisms. 2021 Jun 16; 9(6).
    View in: PubMed
    Score: 0.238
  5. Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient. J Cell Mol Med. 2021 May 25.
    View in: PubMed
    Score: 0.237
  6. Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis. Eur J Clin Pharmacol. 2021 Oct; 77(10):1583-1585.
    View in: PubMed
    Score: 0.236
  7. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. Mediterr J Hematol Infect Dis. 2021; 13(1):e2021016.
    View in: PubMed
    Score: 0.233
  8. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int J Infect Dis. 2021 Apr; 105:49-53.
    View in: PubMed
    Score: 0.232
  9. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
    View in: PubMed
    Score: 0.230
  10. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
    View in: PubMed
    Score: 0.229
  11. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
    View in: PubMed
    Score: 0.228
  12. Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015. Zoonoses Public Health. 2018 08; 65(5):578-583.
    View in: PubMed
    Score: 0.189
  13. Human Zika infection induces a reduction of IFN-? producing CD4 T-cells and a parallel expansion of effector Vd2 T-cells. Sci Rep. 2017 07 24; 7(1):6313.
    View in: PubMed
    Score: 0.182
  14. Different features of Vd2 T and NK cells in fatal and non-fatal human Ebola infections. PLoS Negl Trop Dis. 2017 May; 11(5):e0005645.
    View in: PubMed
    Score: 0.180
  15. Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination. Vaccines (Basel). 2021 Jun 08; 9(6).
    View in: PubMed
    Score: 0.059
  16. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep. 2021 05 31; 11(1):11334.
    View in: PubMed
    Score: 0.059
  17. Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19. Front Pharmacol. 2021; 12:683529.
    View in: PubMed
    Score: 0.059
  18. Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. Int J Infect Dis. 2021 Jun; 107:247-250.
    View in: PubMed
    Score: 0.059
  19. No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison. Front Pharmacol. 2021; 12:621676.
    View in: PubMed
    Score: 0.059
  20. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res. 2021 06; 190:105064.
    View in: PubMed
    Score: 0.059
  21. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.058
  22. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021 04 01; 184(7):1821-1835.e16.
    View in: PubMed
    Score: 0.058
  23. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons. Mol Med. 2001 Jan; 7(1):11-9.
    View in: PubMed
    Score: 0.058
  24. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
    View in: PubMed
    Score: 0.057
  25. Virus-Negative Myopericarditis in Human Coronavirus Infection: Report From an Autopsy Series. Circ Heart Fail. 2020 Nov 12; CIRCHEARTFAILURE120007636.
    View in: PubMed
    Score: 0.057
  26. COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2021 03; 93(3):1796-1804.
    View in: PubMed
    Score: 0.057
  27. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 10 01; 75(10):2977-2980.
    View in: PubMed
    Score: 0.057
  28. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. Int J Infect Dis. 2020 Sep; 98:454-459.
    View in: PubMed
    Score: 0.056
  29. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
    View in: PubMed
    Score: 0.056
  30. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. J Transl Med. 2020 06 10; 18(1):233.
    View in: PubMed
    Score: 0.055
  31. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020 Jul; 96:431-439.
    View in: PubMed
    Score: 0.055
  32. ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC. Mediators Inflamm. 2018; 2018:2450540.
    View in: PubMed
    Score: 0.048
  33. Measles Cases during Ebola Outbreak, West Africa, 2013-2106. Emerg Infect Dis. 2017 06; 23(6):1035-1037.
    View in: PubMed
    Score: 0.045
  34. Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells. J Infect Dis. 2006 May 01; 193(9):1244-9.
    View in: PubMed
    Score: 0.021
  35. T-Cell response profiling to biological threat agents including the SARS coronavirus. Int J Immunopathol Pharmacol. 2005 Jul-Sep; 18(3):525-30.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.